PJ

Pasi A. Jänne

Highly Cited Researcher 2025

Dana-Farber Cancer Institute

Pasi A. Jänne's research focuses on thoracic oncology and the molecular mechanisms of lung cancer, particularly EGFR mutations and resistance to targeted therapies. His work has contributed to the development and clinical evaluation of EGFR inhibitors for non-small cell lung cancer.

Field
Medicine · Oncology
Clarivate categories
Clinical Medicine
Affiliation
Dana-Farber Cancer Institute, United States